ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

34128 results sorted by trial registration date.
  • Optisulin vs NovoMix30 insulin in pregnant women with gestational diabetes

    Insulin therapy is recommended in gestational diabetes when dietary changes have not adequately controlled blood glucose levels. The purpose of this study is to compare the effectiveness of two different types of insulin that we use in treating gestational diabetes, Optisulin® and Novomix30®, in managing fasting blood glucose levels.

  • Comparing the effects of two gym-based exercise programs on balance in adults aged 40 to 64 years

    This study will compare two exercise programs for adults aged 40 to 64 years to determine whether multi-planar functional training is more effective than machine-based strength training for improving balance performance and physical function during midlife. Participants will be randomly allocated to either a machine-based strength training program or a multi-planar functional training program, completed twice per week for 12 weeks at HSCfit, Hunter Sports Centre. Balance performance will be assessed using force plate technology, and lower limb muscle strength and power will be assessed using a countermovement jump test performed on force plate technology. The findings will help inform exercise approaches that may support early prevention of age-related balance decline and future falls risk before older age.

  • An Evaluation of the Safety and Performance of the ProstaCath System for Relieving Urinary Symptoms Secondary to Benign Prostatic Hyperplasia (BPH)

    The goal of this study is to assess the safety and performance of the ProstaCath System for the treatment of lower urinary tract symptoms associated with Benign Prostatic Hyperplasia (BPH) The ProstaCath System is a minimally invasive prostate therapy device with the intention to administer direct current energy to the body for use by healthcare professionals (urologist). Participants will be enrolled in the study over a 6 month period. Each participant will be treated with the ProstaCath System and assessed at 1 and 6 weeks, and 3, 6, and 12 months post treatment to assess symptoms, urine flow, sexual function and adverse events. A subgroup of participants will have an MRI at 1 week to assess the volume and location of ablated tissue. The duration of the study is expected to be 18 months.

  • Targeted exercise for quality of life and physical condition in people who have undergone stoma formation living without a parastomal hernia: a feasibility study

    This co-designed single-arm feasibility study explored whether or not a tailored exercise program was feasible, safe and acceptable to implement, in people living with a stoma and without a parastomal hernia, It was delivered by skilled physiotherapists, with individual personally tailored sessions, face to face over a 3-month period, with 12 people completing the program. It had no major adverse events and those living with a stoma, without a parastomal hernia, reported positive experiences.

  • Public- and private-sector outcomes after open cardiac surgery in patients aged 90 years

    The purpose of this study is to find out whether the number of heart operations performed on people aged 90 years and older in Australia and New Zealand has changed over the past 15 years, and whether patients treated in public hospitals have different outcomes from those treated in private hospitals. To do this, we will look back at existing de-identified records held in a national intensive care registry for every patient aged 90 or older who was admitted to intensive care after open heart surgery, a heart valve operation, a coronary artery bypass, or both together, between 1 January 2010 and 31 December 2024. This is an observational study: we will only study information that has already been collected as part of routine care, so there is no new treatment, no randomisation into groups, and no contact with patients; the two groups being compared are simply patients treated in public hospitals and patients treated in private hospitals. We expect to find that the share of these operations taking place in public hospitals has fallen over time, and this is our main hypothesis; we also want to learn whether the sector of the hospital is linked to a patient's chance of going straight home after surgery, being transferred to another hospital, dying in intensive care or in hospital, or surviving over the following years. Because the two groups of patients may differ from the outset, we will take account of measured differences such as age, sex, type of operation, whether the surgery was planned or urgent, the year of surgery, and the level of social advantage in the area where the patient lives. Finally, we will check how well an existing risk score used in Australian and New Zealand intensive care units predicts death in hospital for patients of this age, so that in future patients and their families can be given more accurate information when deciding whether to proceed with surgery.

  • Feasibility trial of delivering breast and ovarian cancer risk assessment to young people in the general population

    This study is aiming to evaluate the feasibility of a novel shared care model involving general practitioners (GPs) and genetic counsellors (GCs) who will deliver multifactorial breast and ovarian cancer risk assessment to people aged 20-39 years-old Who is it for? You may be eligible to join this study if you are aged between 20 to 39 years old, recorded female at birth and registered as a patient at one of the ten general practices involved in the trial, in metropolitan or regional areas of Victoria. Participating clinics will advertise directly to their eligible clients. Note: this is a trial for people without a diagnosed cancer. Study details This is a 2x2 factorial cluster allocation and randomised feasibility study. All eligible participants will be contacted, informed of the trial and provided with access to a breast and ovarian cancer risk assessment. The mode of the access to the cancer risk assessment will be determined by the how the GP clinic is allocated: either through a GP (GP-facilitated access) or through participant self-access (consumer led-access). After accessing the risk assessment, participants will be asked to provide DNA for testing (saliva test kit) and enter data about their health history and family cancer history into a secure online portal. Study genetic counsellors will then collate the genetic and health history data to generate a breast and ovarian cancer risk assessment result. Consumer participants will then be randomised to receive these results through their GP or by a genetic counsellor. Participants will complete surveys at 2 weeks and 3 months post-results delivery to assess whether they thought the intervention was acceptable and determine effect on psychosocial outcomes such as cancer worry. This feasibility trial will provide important information on how to improve access to multifactorial breast and ovarian cancer risk assessments to the general population. It is hoped that this research will define appropriate access and results-delivery pathways for young people seeking breast and ovarian cancer risk assessments via primary care. By providing access to these breast and ovarian cancer risk assessments at a younger age, it is hoped that young people identified at higher risk of developing cancer will have access to earlier screening and better treatment options.

  • A Phase 2a study comparing the efficacy, safety and tolerability of pregabalin eye drops compared with timolol eye drops in adults with glaucoma or high eye pressure.

    This study is evaluating a new eye drop containing pregabalin (TB0001) as a potential treatment for people with primary open-angle glaucoma or ocular hypertension. The study aims to determine whether TB0001 lowers eye pressure as effectively as timolol, a commonly used glaucoma eye drop, while remaining safe and well tolerated. Participants will be randomly assigned to receive one of three strengths of TB0001 or timolol for 28 days. Eye pressure, eye health, side effects and tolerability will be assessed throughout the study. The results will help identify the most appropriate dose of TB0001 for future clinical studies.

  • Impact of a Telehealth Clinical Reformer- versus Mat-based Pilates on metabolic syndrome severity among women with a history of gestational diabetes mellitus: a pilot mixed-methods study

    Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among women. The postpartum period, marked by physiological changes of pregnancy, can exacerbate existing CVD risk factors and presents an ideal opportunity for prevention. Postpartum women at high risk for CVD often receive insufficient targeted care, leading to missed opportunities for early intervention and prevention. This pilot research study aims to investigate the impact of a novel Telehealth Clinical Pilates program specifically designed for postpartum women at high risk of CVD. Addressing this gap is crucial for improving maternal health outcomes and reducing long-term chronic disease and associated healthcare costs. The insights gained from this pilot study could inform larger, more comprehensive studies and ultimately lead to significant changes in postpartum care practices.

  • ACE2.0 Hearing Program: Evaluating a Group-Based Communication and Wellbeing Intervention for Adults with Hearing Loss and Their Families

    The ACE Your Hearing study aims to improve the lives of adults over 50 with hearing loss and their families by providing a redesigned communication and wellbeing program. The primary purpose is to test if this modular, psychosocially-focussed program is more effective than standard care in reducing loneliness and improving emotional wellbeing. We hypothesise that participants who complete the program will report significantly better social participation and communication success compared to those receiving treatment-as-usual. To ensure these benefits reach the community, the study is being conducted within real-world hearing clinics to evaluate how easily the program can be integrated into everyday business operations. Ultimately, this research seeks to transform hearing care from a focus on devices alone to a holistic approach that supports the overall quality of life for Australians with hearing loss.

  • Does a multidisciplinary shared decision-making pathway influence decision quality in adults considering surgery for benign skin lumps?

    This study aims to find out whether a structured decision-making pathway can help adults make better-informed choices when considering treatment for benign skin lumps. Patients are supported by clinic staff and nurses to identify what matters most to them, and then discuss with their doctor the benefits and disadvantages of options such as surgery, less invasive treatment, or having no procedure. We expect that this approach will help patients choose treatment that better matches their personal priorities and expectations and will reduce regret about their decision afterwards. The outcomes of patients receiving this pathway will also be considered in comparison with information from patients who received usual care before the pathway was introduced.

Tags:
  • Finding clinical trials